Science, global health, and irrational health behaviors

Ed. Note: Sara Gorman will be joining us once a month to highlight different aspects of her forthcoming book on science denialism.  Have you ever Read More


Accelerating an Integrated Approach to NCD Prevention and Control Globally

Dr. Samira Asma, Chief, Global NCD Program, CDC Over the past 18 years, I’ve worked with Ministries of Health and other partners in 180 countries to advance CDC’s overarching global health goals and accelerate strategies for the prevention and control of noncommunicable diseases (NCDs) and injuries. NCDs and injuries are responsible for millions of premature deaths, especially in low- and middle-income counties (LMICs). As public health practitioners, we have an important opportunity to work collaboratively to accelerate and scale up implementation of proven prevention and treatment strategies and measure their impact.


“Ketamine: a growing global health-care need”

  Ketamine is a valued anesthetic tool in all clinical practice settings. In LMICs, however, ketamine is indispensable for addressing the growing burden of surgical Read More


Knowledge of the signs and symptoms and risk factors of lung cancer in Australia: mixed methods…

Lung cancer is the leading cause of cancer death in Australia.

Routine screening of Indigenous cancer patients’ unmet support needs: a qualitative study of…

Indigenous Australians have poorer cancer outcomes in terms of incidence mortality and survival compared with non-Indigenous Australians.

Socioeconomic disparities in lung cancer mortality in Belgian men and women (2001-2011): does…

Ample studies have observed an adverse association between individual socioeconomic position (SEP) and lung cancer mortality.

Cancer Drugs Cost Less In Poorer Nations But Not More Affordable, Study Shows

Associated Press: Study: Cancer drugs less affordable in poor nations than U.S. “Cancer drugs predictably cost much more in the U.S. than in poor countries and even other wealthy nations, but a study shows they are less affordable in some developing countries despite the lower price. Relative to their ability to pay, cancer patients in…More

PLOS Medicine Podcast episode 1: The Actionable Cancer Genome

PLOS Medicine’s Senior Research Editor Clare Garvey interviews Elaine Mardis and Marc Ladanyi, Guest Editors for our Special Issue on the Actionable Cancer Genome ; Elaine Mardis is co-Director of the McDonnell Genome Institute and Robert E. and

Blog Post Examines Challenges To Addressing Breast Cancer In Haiti, Progress In Care

Humanosphere: In Haiti, breast cancer doesn’t need to be a death sentence Humanosphere journalist Lisa Nikolau discusses the challenges to addressing breast cancer in Haiti, citing fear, stigma, and a lack of support for patients. However, she notes progress, writing, “There’s no doubt that cancer care in Haiti has a long road to navigate before…More

In Haiti, breast cancer doesn’t need to be a death sentence

Cancer kills more people in low- and middle-income countries than HIV/AIDS, tuberculosis and malaria combined. And for people in the developing world – where the survival rate of breast cancer is less than half that of high-income countries – breast cancer can seem like a death sentence.  But it doesn’t need to be – not

Large Non-Profit Foundations Serve As Important Funding Sources For, Can Profit From Biotech…

Reuters: How Wellcome and Gates charities profit from helping biotech “The Wellcome Trust medical charity is to profit from U.S. approval of a new diagnostic cancer test, the first commercial product funded by the organization since the sale of its pharmaceuticals business to Glaxo in 1995. The regulatory green light shows how the world’s health…More

Menstrual health education: a key to nurturing confident girls

Anshu, a teenager who lives in a village in Raebareli District of Uttar Pradesh, India, was a friendly and lively girl. But when she reached puberty, she had very little information about how to manage her menstruation, and she began to lose her confidence. During those days each month she did not venture out from her […] ; ; ; ;Related StoriesHealthy markets: essential to improving health and saving livesThe profound effect of girls’ dreamsJosé Jerónimo: a cancer hero among us ;

WHA69: Leave no one behind, World Hepatitis Alliance

Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week). Raquel’s piece is part of a series of articles Translational Global Health will run on WHA69. If you or your organisation have a particular focus at the Assembly you feel requires urgent attention, contact our Editor. We are at a turning point. This week, 194 countries will convene to decide the fate of millions of people living with viral hepatitis. At the 69th World Health Assembly in Geneva (23 – 28 May), governments will deliberate on the adoption of WHO’s first ever Global Health Sector Strategy for Viral Hepatitis (GHSS), which sets a goal of eliminating hepatitis B and C by 2030, two significant public health issues that can lead to cirrhosis, liver cancer and death.

Science, global health, and irrational health behaviors


Ed. Note: Sara Gorman will be joining us once a month to highlight different aspects of her forthcoming book on science denialism.  Have you ever Read More

A vision for improved cancer screening in Nigeria

As the global burden of disease shifts from infectious diseases to non-communicable diseases (NCDs), cancer has increasingly become a major contributor to morbidity and mortality in low-income and middle-income countries (LMICs). Major reasons for these shifts include increasing life expectancy and changing diets and lifestyles. An estimated 14·1 million new cases and 8·2 million cancer deaths occurred worldwide in 2012, with more than 65% of cancer deaths occurring in LMICs.1 In Nigeria, cervical cancer and breast cancer are two of the leading causes of cancer deaths in women, accounting for more than 40% of all women’s cancer and about two-thirds of cancer deaths.

Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the…

Publication date: June 2016 Source:Social Science & Medicine, Volume 159 Author(s): Kayoll V.

José Jerónimo: a cancer hero among us

Recently, PATH’s Dr. José Jerónimo received the highest award that the American Society for Colposcopy and Cervical Pathology (ASCCP) can bestow—the Distinguished Scientific Award for significant positive impact on underserved populations. ASCCP works on cervical health worldwide and recognized Jose for his contributions in low-resource settings. José will be presenting a talk on cervical cancer […] ; ; ; ;Related StoriesHealthy markets: essential to improving health and saving livesPolio, pride, and love: the story of an exceptional mother and her sonKeeping a promise to mothers and children ;

Older Posts »